|
|
||||||||||
|
J Am Coll Cardiol, 1993; 22:1044-1051 © 1993 by the American College of Cardiology Foundation |
Department of Medicine, University of Ottawa, Ontario, Canada.
OBJECTIVES. This retrospective study sought to estimate patient radiation exposure during percutaneous transluminal coronary angioplasty, the corresponding organ doses and the resulting cancer mortality risk. Patient demographic data were also examined. BACKGROUND. Coronary angioplasty is commonly used as an intervention for coronary atherosclerosis, and repeated application in the same patient is now common. The combined use of fluoroscopy and cineradiography in this complicated, delicate and, hence, lengthy procedure induced us to investigate the patient radiation exposures and resulting risks. METHODS. All complete records for angioplasty procedures performed over a 3-year period were entered into a data base. The data comprised 1,893 procedures performed in a total of 1,503 patients, of whom 21% had two or more procedures in the 3-year period. Fluoroscopy time was converted to entrance exposures, assuming a rate of 520 muC kg-1 min-1 (2.0 R min-1). Cineradiographic film lengths were determined for a smaller number of procedures (200) and converted to exposures at 7.7 muC kg-1 frame-1 (30 mR frame-1). In addition, fluoroscopy and cineradiographic times and, hence, exposures for 91 diagnostic angiograms performed in these patients were obtained. Exposures were converted to organ doses using the Monte Carlo results of the Rosenstein group and then to cancer mortality risks using the latest rates of the International Commission on Radiological Protection. RESULTS. The mean age was 56.0 years; men constituted 77.5% of the patients. Radiation doses varied considerably owing to a large spread in exposure times (e.g., fluoroscopy time per angioplasty case averaged 19 min but for some cases exceeded 1 h). The average patient skin entrance exposure per angioplasty procedure was 32.0 mC kg-1 (124 R), of which 69.7% was from cineradiography. The resulting cancer mortality risk per angioplasty procedure is approximately 8 x 10(-4). CONCLUSIONS. The skin exposures estimated for angioplasty are on average higher than for other X-ray procedures. The cancer mortality risk does not exceed the mortality risk of bypass surgery. Good professional practice requires maximization of the benefit/risk ratio through quality assurance in all aspects of the procedure.
This article has been cited by other articles:
![]() |
E. Bogaert, K. Bacher, and H. Thierens A large-scale multicentre study in Belgium of dose area product values and effective doses in interventional cardiology using contemporary X-ray equipment Radiat Prot Dosimetry, February 1, 2008; 128(3): 312 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Brasselet, T. Blanpain, S. Tassan-Mangina, A. Deschildre, S. Duval, F. Vitry, N. Gaillot-Petit, J. P. Clement, and D. Metz Comparison of operator radiation exposure with optimized radiation protection devices during coronary angiograms and ad hoc percutaneous coronary interventions by radial and femoral routes Eur. Heart J., January 1, 2008; 29(1): 63 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kirisits, A. Hefner, P. Wexberg, B. Pokrajac, D. Glogar, R. Potter, and D. Georg Estimation of doses to personnel and patients during endovascular brachytherapy applications Radiat Prot Dosimetry, February 1, 2004; 108(3): 237 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Larrazet, A Dibie, F Philippe, R Palau, R Klausz, and F Laborde Factors influencing fluoroscopy time and dose-area product values during ad hoc one-vessel percutaneous coronary angioplasty Br. J. Radiol., July 1, 2003; 76(907): 473 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, D. Hoss, and T. J. Phillips Fluoroscopy-Induced Skin Necrosis Arch Dermatol, February 1, 2003; 139(2): 140 - 142. [Full Text] [PDF] |
||||
![]() |
T. R. Koenig, D. Wolff, F. A. Mettler, and L. K. Wagner Skin Injuries from Fluoroscopically Guided Procedures: Part 1, Characteristics of Radiation Injury Am. J. Roentgenol., July 1, 2001; 177(1): 3 - 11. [Full Text] [PDF] |
||||
![]() |
T. R. Koenig, F. A. Mettler, and L. K. Wagner Skin Injuries from Fluoroscopically Guided Procedures: Part 2, Review of 73 Cases and Recommendations for Minimizing Dose Delivered to Patient Am. J. Roentgenol., July 1, 2001; 177(1): 13 - 20. [Full Text] [PDF] |
||||
![]() |
M. Mahesh Fluoroscopy: Patient Radiation Exposure Issues RadioGraphics, July 1, 2001; 21(4): 1033 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
P WILDE, E M PITCHER, and K SLACK Radiation hazards for the patient in cardiological procedures Heart, February 1, 2001; 85(2): 127 - 130. [Full Text] |
||||
![]() |
E Vano, L Gonzalez, J I Ten, J M Fernandez, E Guibelalde, and C Macaya Skin dose and dose-area product values for interventional cardiology procedures Br. J. Radiol., January 1, 2001; 74(877): 48 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Dehen, C Vilmer, C Humilière, T Corcos, D Pentousis, L Ollivaud, D Chatelain, and L Dubertret Chronic radiodermatitis following cardiac catheterisation: a report of two cases and a brief review of the literature Heart, March 1, 1999; 81(3): 308 - 312. [Abstract] [Full Text] |
||||
![]() |
J. T. Cusma, M. R. Bell, M. A. Wondrow, J. P. Taubel, and D. R. Holmes Jr. Real-time measurement of radiation exposure to patients during diagnostic coronary angiography and percutaneous interventional procedures J. Am. Coll. Cardiol., February 1, 1999; 33(2): 427 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Waksman, K. A. Robinson, I. R. Crocker, C. Wang, M. B. Gravanis, G. D. Cipolla, R. A. Hillstead, and S. B. King III Intracoronary Low-Dose ß-Irradiation Inhibits Neointima Formation After Coronary Artery Balloon Injury in the Swine Restenosis Model Circulation, November 15, 1995; 92(10): 3025 - 3031. [Abstract] [Full Text] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |